Since sparse literature exists regarding the value of EGFR expression in blood of advanced stage lung cancer patients, the prognostic significance of EGFR expression in lung cancer and, more importantly, its ability to predict response to anti-EGFR therapies, are currently subjects of active research. This evidence concerns the gene EGFR and lung carcinoma.